Effect of medication withdrawal on the interictal epileptiform EEG discharges in presurgical evaluation

Noémi Becser Andersen1, Jørgen Alving, Sándor Beniczky

  • 1Danish Epilepsy Centre, Kolonivej 1, 4293 Dianalund, Denmark. noemi@dadlnet.dk

Seizure
|February 5, 2010
PubMed

Insights

Medication withdrawal (MW) effectively provokes seizures and epileptiform activity for epilepsy surgery diagnosis. This method reliably identifies the irritative zone without causing false localization, enhancing diagnostic accuracy.

Area of Science:

  • Neurology
  • Epileptology
  • Neurosurgery

Background:

  • Medication withdrawal (MW) is crucial for diagnosing epilepsy surgery candidates by provoking seizures.
  • Concerns exist that MW may alter seizure types and EEG findings, potentially leading to mislocalization of the seizure focus.

Purpose of the Study:

  • To evaluate the impact of MW on seizure frequency, seizure types, and EEG localization of epileptiform discharges.
  • To determine if MW leads to false localization of the irritative zone in epilepsy surgery evaluations.

Main Methods:

  • Retrospective review of 42 medication withdrawal cases from 36 patients over 3 years.
  • Comparison of seizure frequency, seizure types, and interictal epileptiform discharge localization before and after MW.

Main Results:

  • Seizure frequency significantly increased after MW.
  • Increased seizure propagation observed, with a rise in complex partial and secondarily generalized seizures, and a decrease in simple partial seizures.
  • EEG findings changed in one-third of patients post-MW, but these changes correctly localized the seizure onset and lesional zones.

Conclusions:

  • Medication withdrawal is an effective and reliable method for provoking seizures and epileptiform activity.
  • MW does not result in false localization of the irritative zone, supporting its use in epilepsy surgery work-up.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...